These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Could proteinuria evaluation be helpful in predicting renal progression in apolipoprotein E-deficient (E-/-) mice with chronic renal failure? Ivanovski O; Nguyen-Khoa T; Phan O; Massy ZA Nephrol Dial Transplant; 2004 Apr; 19(4):1013-4; author reply 1014. PubMed ID: 15031372 [No Abstract] [Full Text] [Related]
24. Treatment options for end stage renal disease. Crawford PW; Lerma EV Prim Care; 2008 Sep; 35(3):407-32, v. PubMed ID: 18710662 [TBL] [Abstract][Full Text] [Related]
31. Treatment of chronic renal failure. Anderson CF Minn Med; 1974 May; 57(5):364-7. PubMed ID: 4824716 [No Abstract] [Full Text] [Related]
32. [Study of renal function in renal insufficiency. I. Renal function of the patients under chronic hemodialysis]. Kawamura J; Okabe T; Yamashita A; Sawanishi K; Katõ T Hinyokika Kiyo; 1971 Mar; 17(3):157-86. PubMed ID: 5103947 [No Abstract] [Full Text] [Related]
33. Hypertension and renal insufficiency: recognition and management. Moore MA; Porush JG Am Fam Physician; 1992 Mar; 45(3):1248-56. PubMed ID: 1543108 [TBL] [Abstract][Full Text] [Related]
34. [The nomenclature and concept of care of children and adolescents with renal insufficiency]. Janda J; Spatenka J; Krolupper M Cesk Pediatr; 1989 Apr; 44(4):196-8. PubMed ID: 2736643 [TBL] [Abstract][Full Text] [Related]
35. A cutaneous disease with multisystem involvement: hypomelanosis of Ito may be associated with proteinuria, focal segmental glomerulosclerosis and end-stage renal disease. Gatter N; Hoppe B; Nützenadel F; Waldherr R; Querfeld U Nephrol Dial Transplant; 2007 Jun; 22(6):1796-8. PubMed ID: 17347282 [No Abstract] [Full Text] [Related]
36. [Chronic renal insufficiency (its diagnosis and treatment)]. Lopatkin NA; Kuchinskiĭ IN Ter Arkh; 1973 May; 45(5):18-25. PubMed ID: 4768368 [No Abstract] [Full Text] [Related]
37. Early detection of progressive chronic kidney disease: is it feasible? Gansevoort RT; Bakker SJ; de Jong PE J Am Soc Nephrol; 2006 May; 17(5):1218-20. PubMed ID: 16611711 [No Abstract] [Full Text] [Related]
38. [Renal insufficiency in myelomatosis. Causes and treatment]. Knudsen LM; Hansen MT; Hippe E; Løkkegaard H Ugeskr Laeger; 1993 Nov; 155(47):3823-7. PubMed ID: 8256382 [TBL] [Abstract][Full Text] [Related]
39. [Effect of hemodialysis on tubular electrolyte transport in chronic kidney insufficiency]. Emanuél' VI; Riabov SI; Monin IuG; Spiridonov VN; Lavrova EA Urol Nefrol (Mosk); 1980; (3):55-9. PubMed ID: 7385480 [No Abstract] [Full Text] [Related]
40. [Treatment of chronic kidney insufficiency. After a symposium in the Swedish Medical Society, 10 October 1967]. Bergström J; Franksson C; Kistner S; Lindholm T Nord Med; 1968 Oct; 80(40):1309-17. PubMed ID: 4880019 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]